Proteon founders launch new company Novita
This article was originally published in Scrip
Executive Summary
The founders of Proteon Therapeutics have launched a new venture, Novita Therapeutics, and closed a first round of financing from angel investors. The new firm will focus on biopharmaceuticals and medical devices to treat cardiovascular, renal and gastrointestinal diseases.